Article
COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention.
European journal of gastroenterology & hepatology - 1 May 2010
Pereira Carina, Pimentel-Nunes Pedro, Brandão Catarina, Moreira-Dias Luís, Medeiros Rui, Dinis-Ribeiro Mário
Abstract excerpt
OBJECTIVE: COX-2, the inducible isoenzyme, was found to be overexpressed in approximately 85% of colorectal adenocarcinomas, contributing to key steps in tumor development. COX-2 polymorphisms that might modify the levels of protein expression would be anticipated to have a substantial influence on disease phenotype. Therefore, we sought to understand the role of three COX-2 polymorphisms (-1195A>G, -765G>C, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
